Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Completed

Conditions studied: Osteoporosis, Age-Related

In brief

The objective of this study was to describe persistence with Prolia® 60 mg administered subcutaneously (SC) every 6 months (Q6M) at 12 and 24 months.

Key facts

Study ID

NCT02732210

Run by

Amgen

People needed

935

Starts

2011-07-06

Expected to finish

2014-04-14

Last updated by the study team

2022-11-29

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Enrollment within 4 weeks following administration of the first Prolia® (denosumab 60 mg) injection
• Received Prolia® subcutaneously for treatment of osteoporosis consistent with local (US/Canada) product label
• Subject or subject's legally acceptable representative has provided informed consent. Exclusion Criteria:
• Participation in ongoing or previous denosumab clinical trials
• Currently enrolled in another investigational device or drug study, or less than 6 months since ending another investigational device or drug study(s), or receiving other investigational agent(s)
• Contra-indicated for treatment with Prolia® according to the approved applicable local product label (US/Canada)
• Subject has any kind of disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent.

Where it is running

• Research Site — Chandler, Arizona, United States
• Research Site — Peoria, Arizona, United States
• Research Site — Phoenix, Arizona, United States
• Research Site — Hemet, California, United States
• Research Site — Laguna Hills, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Murrieta, California, United States
• Research Site — Oxnard, California, United States
• Research Site — Santa Maria, California, United States
• Research Site — Santa Monica, California, United States
• Research Site — South Lake Tahoe, California, United States
• Research Site — Victorville, California, United States
• Research Site — Lakewood, Colorado, United States
• Research Site — Trumbull, Connecticut, United States
• Research Site — Fort Myers, Florida, United States
• Research Site — Hollywood, Florida, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Kissimmee, Florida, United States
• Research Site — Pembroke Pines, Florida, United States
• Research Site — Sebring, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Gainesville, Georgia, United States
• Research Site — Woodstock, Georgia, United States
• Research Site — Alton, Illinois, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.